Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage i NSCLC: Comparison with a contemporaneous cohort with pathologically proven disease

Radiotherapy and Oncology

Volumn 101, Issue 2, 2011, Pages 250-254

  Verstegen, Naomi E ^a   Lagerwaard, Frank J ^a   Haasbeek, Cornelis J A ^a   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical diagnosis; Pathology; Stage I non small cell lung cancer; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RIB FRACTURE; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; TRANSTHORACIC BIOPSY; TREATMENT OUTCOME; TUMOR ABLATION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81755185453     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.09.017     Document Type: Article

References (34)

1. F.G. Detterbeck, and C.J. Gibson Turning fray: the natural history of lung cancer over time J Thorac Oncol 3 2008 781 792
2. W.J. Scott, J. Howington, S. Feigenberg, B. Movsas, and K. Pisters Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 234S 242S (Pubitemid 47502810)
3. D. Palma, and S. Senan Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer Curr Opin Oncol 23 2011 133 139
4. D. Palma, O. Visser, F.J. Lagerwaard, J. Belderbos, B.J. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
5. N. Sawabata, M. Ohta, and A. Matsumura Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Ann Thorac Surg 77 2004 415 420 (Pubitemid 38186481)
6. S. Sawada, M. Yamashita, and E. Komori Evaluation of resected tumors that were not diagnosed histologically but were suspected of lung cancer preoperatively J Thorac Oncol 2 2007 S422
7. S. Sato, T. Koike, and Y. Yamato Diagnostic yield of preoperative computed tomography imaging and the importance of a clinical decision for lung cancer surgery Gen Thorac Cardiovasc Surg 58 2010 461 466
8. T. Hiraki, H. Mimura, and H. Gobara CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure Chest 136 2009 1612 1617
9. F. Laurent, M. Montaudon, V. Latrabe, and H. Bégueret Percutaneous biopsy in lung cancer Eur J Radiol 45 2003 60 68 (Pubitemid 36020311)
10. S.J. Swensen, M.D. Silverstein, D.M. Ilstrup, C.D. Schleck, and E.S. Edell The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules Arch of Int Med 157 1997 849 855 (Pubitemid 28337035)
11. G.J. Herder, H. van Tinteren, and R.P. Golding Clinical prediction model to characterize pulmonary nodules: validation and added value of 18Ffluorodeoxyglucose positron emission tomography Chest 128 2005 2490 2496 (Pubitemid 41507599)
12. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
13. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
14. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
15. P. Baumann, J. Nyman, and M. Hoyer Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367
16. H. van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1393
17. 18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study J Clin Oncol 24 2006 1800 1806 (Pubitemid 46638976)
18. E.H. Belgers, J. Siebenga, A.M. Bosch, E.H. van Haren, and E.C. Bollen Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in The Netherlands Interact Cardiovasc Thorac Surg 10 2010 176 180
19. R.J. Cerfolio, and A.S. Bryant Survival of patients with true pathologic stage I non-small cell lung cancer Ann Thorac Surg 88 2009 917 922
20. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346 (Pubitemid 26342716)
21. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
22. K.L. Stephans, T. Djemil, and C.A. Reddy A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience J Thorac Oncol 4 2009 976 982
23. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
24. A. Chi, Z. Liao, N.P. Nguyen, J. Xu, B. Stea, and R. Komaki Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
25. D. Palma, O. Visser, and F.J. Lagerwaard Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery Radiother Oncol 101 2011 240 244
26. S.J. Swensen, J.R. Jett, and T.E. Hartman CT screening for lung cancer: five-year prospective experience Radiology 235 2005 259 265 (Pubitemid 40432263)
27. U. Pastorino, M. Bellomi, and C. Landoni Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results Lancet 362 2003 593 597 (Pubitemid 37013298)
28. G. Veronesi, M. Bellomi, and J.L. Mulshine Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules Lung Cancer 61 2008 340 349
29. B.J. May, J.M. Levsky, and A. Godelman Should CT play a greater role in preventing the resection of granulomas in the Era of PET? AJR Am J Roentgenol 196 2011 795 800
30. B. Fischer, U. Lassen, and J. Mortensen Preoperative staging of lung cancer with combined PET-CT N Engl J Med 361 2009 32 39
31. C.M. Mery, A.N. Pappas, and R. Bueno Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule Chest 125 2004 2175 2181 (Pubitemid 38788187)
32. S. Siva, M. MacManus, and D. Ball Stereotactic radiotherapy for pulmonary oligometastases: a systematic review J Thorac Oncol 5 2010 1091 1099
33. H. Kim, Y.C. Ahn, H.C. Park, H. Lim do, and H. Nam Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer J Thorac Oncol 5 2010 526 532
34. A. Takeda, E. Kunieda, and T. Ohashi Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer Radiother Oncol 101 2011 255 259